The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress?
Abstract
BACKGROUND: Adrenocortical carcinoma (ACC), a rare and aggressive malignancy, accounts for up to 14% of adrenal incidentalomas. The only chance of cure for ACC is diagnosis at an early stage; therefore, a main indication for adrenalectomy in patients with adrenal incidentaloma has been the potential risk of ACC. Recent studies suggest that this has led to earlier stage of ACC at diagnosis, more curative operations, and better survival. METHODS: We analyzed data on ACC from The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database. Four equal time quartiles (1973-1979, 1980-1986, 1987-1993, and 1994-2000) were compared for changes in demographics, pathology, treatment, and cause-specific mortality. RESULTS: The average age was 51.2 years (range: 1-97), and 45.9% of patients were men. The average tumor size was 12 cm (range: 2-36 cm), and only 4.2% were < or = 6 cm. Most (88%) patients had surgical resection of their tumor, and external beam radiotherapy was used in only 12% of patients. Between the time quartiles compared (as well as annually), there was no significant difference at presentation in age at diagnosis, sex, race/ethnicity, tumor size, tumor grade, the frequency of distant metastasis, and overall TNM stage. Low tumor grade, lower stage of ACC, later time quartile, and surgical resection were associated with a lower cause-specific mortality by univariate analysis (P < or = 0.002) and by multivariate analysis (P < or = 0.031). CONCLUSIONS: Although adrenal incidentalomas have become a common indication for adrenalectomy, this has not resulted in patients with ACC being diagnosed earlier or treated at a lower stage of disease at the national level. The most important predictors of survival in these patients are tumor grade, tumor stage, and surgical resection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Surveillance, Epidemiology, and End Results (SEER) database provides an estimation of incidence of approximately 0.72 per million cases per year leading to 0.2% of all cancer deaths in the United States (4).”
From Adrenocortical carcinoma (2014) · cites this paper as [4]
In the citing paper
“In the United States, it is used in approximately 10% of cases, according to analyses of both the National Cancer Data Base and the SEER program (4, 11, 90).”
From Adrenocortical carcinoma (2014) · cites this paper as [4]
Citations
Cites
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Dackiw, A. P. B., Lee, J. E., Gagel, R. F., & Evans, D. B. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0030-7 · Cited by 390
Schulick, R. D., & Brennan, M. F. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0719-7 · Cited by 366
Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization
Stojadinovic, A., Ghossein, R. A., Hoos, A., Nissan, A., Marshall, D., Dudas, M. E., Cordon‐Cardo, C., Jaques, D. P., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.4.941 · Cited by 312
de Fraipont, F., El Atifi, M., Cherradi, N., Le Moigne, G., Defaye, G., Houlgatte, R., Bertherat, J., Bertagna, X., Plouin, P.-F., Baudin, E., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1075 · Cited by 261
Survival Variability by Race and Ethnicity in Childhood Acute Lymphoblastic Leukemia
Kadan‐Lottick, N. S. (2003) · JAMA · doi:10.1001/jama.290.15.2008 · Cited by 238
Management of adrenocortical carcinoma
Allolio, B., Hahner, S., Weismann, D., & Fassnacht, M. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01881.x · Cited by 214
Kendrick, M. L. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.5.543 · Cited by 140
Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection
Harrison, L. E. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.2.181 · Cited by 117
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1200/JCO.20.4.941 · DOI
Cited by
Sorted by citations
Items 201–300 of 450
Laparoscopic transabdominal lateral adrenalectomy
Bickenbach, K. A., & Strong, V. E. M. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23250 · Cited by 12
Ganeshan, D., Bhosale, P., & Kundra, V. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.8282 · Cited by 12
Prinzi, A., Guarnotta, V., Dalmazi, G. D., Canu, L., Ceccato, F., Ferraù, F., Badalamenti, G., Albertelli, M., Martino, M. C. D., Fanciulli, G., et al. (2025) · Endocrine Pathology · doi:10.1007/s12022-025-09857-0 · Cited by 11
Xiao, W.-J., Zhu, Y., Dai, B., Zhang, H., Shi, G., Shen, Y.-J., Zhu, Y., & Ye, D. (2015) · Oncotarget · doi:10.18632/oncotarget.5831 · Cited by 11
Balderrama-Brondani, V., Montenegro, L. R., Lacombe, A. M. F., Magalhães, B. M., Nishi, M. Y., Funari, M. F. A., Narcizo, A. D. M., Cardoso, L. C., Siqueira, S. A. C., Zerbini, M. C. N., et al. (2020) · Cancers · doi:10.3390/cancers12030621 · Cited by 11
Tian, X., Xu, W., Anwaier, A., Wang, H., Wan, F., Cao, D., Luo, W., Shi, G., Qu, Y., Zhang, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16323 · Cited by 11
Heinze, B., Herrmann, L., Faßnacht, M., Ronchi, C. L., Willenberg, H. S., Quinkler, M. O., Reisch, N., Zink, M., Allolio, B., & Hahner, S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0788 · Cited by 11
Ru, W., Yang, M., Xu, S., Li, M.-J., & Tang, D. (2017) · Pediatric Surgery International · doi:10.1007/s00383-017-4073-8 · Cited by 11
Bulzico, D., Torres, D. C., Ferreira, G. M., Pires, B. R. B., de Faria, P. A. S., Hassan, R., Abdelhay, E. S. F. W., Vaisman, M., & Neto, L. V. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9482-7 · Cited by 11
Gara, S. K., Tyagi, M. V., Patel, D. T., Gaskins, K., Lack, J., Liu, Y., & Kebebew, E. (2020) · Oncotarget · doi:10.18632/oncotarget.27703 · Cited by 11
Adrenocortical Carcinoma: The Value of Lymphadenectomy
Tseng, J., DiPeri, T. P., Chen, Y., Shouhed, D., Ben-Shlomo, A., Burch, M. A., Phillips, E. H., & Jain, M. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-11051-5 · Cited by 11
Hasanovic, A., Simsir, M., Choveau, F. S., Lalli, E., & Mus‐Veteau, I. (2020) · Biomedicines · doi:10.3390/biomedicines8080251 · Cited by 10
Adrenocortical Carcinoma: Modern Management and Evolving Treatment Strategies
McDuffie, L. A., & Aufforth, R. (2016) · International Journal of Endocrine Oncology · doi:10.2217/ije-2015-0003 · Cited by 10
Ettaieb, M. H. T., van Kuijk, S. M. J., de Wit-Pastoors, A., Feelders, R. A., Corssmit, E. P. M., Eekhoff, E. M. W., van der Valk, P., Timmers, H. J. L. M., Kerstens, M. N., Klümpen, H., et al. (2020) · Cancers · doi:10.3390/cancers12092720 · Cited by 10
Asadi, A. A., Hubbs, D., Sweigert, P. J., Baker, M. S., & Kabaker, A. S. (2020) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2020.10.038 · Cited by 10
Tsoli, M., Daskalakis, K., Kassi, E. N., Kaltsas, G., & Tsolakis, A. V. (2021) · Biology · doi:10.3390/biology10070580 · Cited by 10
Tseng, J., DiPeri, T. P., Gonsalves, N. R., Chen, Y., Ben-Shlomo, A., Shouhed, D., Phillips, E. H., Burch, M. A., & Jain, M. (2022) · Surgical Endoscopy · doi:10.1007/s00464-022-09167-0 · Cited by 10
Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels
Lin, X., Gu, Y. J., Su, Y., Dong, Y., Major, P. P., Kapoor, A., & Tang, D. (2022) · Cancers · doi:10.3390/cancers14112805 · Cited by 9
Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?
Costa, R., Wesolowski, R., & Raghavan, D. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10464.x · Cited by 9
Adrenocortical Carcinoma and Synchronous Malignancies
Guerrero, M. A., & Kebebew, E. (2010) · Journal of Cancer · doi:10.7150/jca.1.108 · Cited by 9
Zhang, H., Naji, Y., Yan, M., Lian, W., Xie, M., & Dai, Y. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02413-1 · Cited by 9
Gene-expression profiling of adrenocortical carcinoma
Suh, I., Guerrero, M. A., & Kebebew, E. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.13 · Cited by 9
Beyond a Disease Registry: An Integrated Virtual Environment for Adrenal Cancer Research
Sinnott, R., Beuschlein, F., Effendy, J., Eisenhofer, G., Gloeckner, S., & Stell, A. (2016) · Journal of Grid Computing · doi:10.1007/s10723-016-9375-x · Cited by 9
Soon, P. S. H., & Sidhu, S. B. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0857-5_11 · Cited by 9
Systemic Management of Advanced Adrenocortical Carcinoma
Russell, J. S. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01249-6 · Cited by 9
Adrenal Surgery for Synchronously Metastatic Adrenocortical Carcinoma: A Population‐Based Analysis
Wu, K., Liu, Z., Li, X., & Lu, Y. (2021) · World Journal of Surgery · doi:10.1007/s00268-021-05957-0 · Cited by 8
Machine Learning–Based Survival Prediction Tool for Adrenocortical Carcinoma
Saygılı, E. S., Elhassan, Y., Prete, A., Lippert, J., Altieri, B., & Ronchi, C. L. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf096 · Cited by 9
Expression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma
Wu, K., Liu, Z., Liang, J., Zhang, F., Zhang, F., Wang, Y., Lia, T., Liu, S., Zhu, Y., & Li, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903824 · Cited by 8
Treatment Differences for Adrenocortical Carcinoma by Race and Insurance Status
Holoubek, S. A., MacKinney, E. C., Khokar, A. M., Kuchta, K. M., Winchester, D. J., Prinz, R. A., & Moo‐Young, T. A. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.05.011 · Cited by 8
Adrenal incidentalomas and subclinical Cushing’s syndrome
Abdelmannan, D. K., & Aron, D. C. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9141-5 · Cited by 8
Competing Endogenous RNA Network Analysis Reveals Pivotal ceRNAs in Adrenocortical Carcinoma
Liang, W., & Sun, F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00301 · Cited by 7
Metallothionein protein and minichromosome maintenance protein-2 expression in adrenocortical tumors
Saiegh, L., Sheikh‐Ahmad, M., Shechner, C., Reut, M., Darawsha, Y., Zolotov, S., Shefer, H. K., Bejar, I., & Bejar, J. (2019) · Annales d Endocrinologie · doi:10.1016/j.ando.2019.09.003 · Cited by 8
Indoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma
Tierney, J. F., Vogle, A., Finnerty, B. M., Zarnegar, R., Ghai, R., Gattuso, P., Fahey, T. J., & Keutgen, X. M. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.06.016 · Cited by 8
Peixoto, R., Gomes, L. B. M., Sousa, T., Racy, D., Shigenaga, M. K., & Nagourney, R. (2018) · Rare Tumors · doi:10.1177/2036361317749645 · Cited by 8
Laparoscopic adrenalectomy for the management of benign and malignant adrenal tumors
Cyriac, J., Weizman, D., & Urbach, D. R. (2006) · Expert Review of Medical Devices · doi:10.1586/17434440.3.6.777 · Cited by 8
Surgical Management and Clinical Prognosis of Adrenocortical Carcinoma
Dong, D., Li, H., Yan, W., Ji, Z., & Mao, Q. (2012) · Urologia Internationalis · doi:10.1159/000336134 · Cited by 8
Long Non-Coding RNA H19 Expression Correlates with Autophagy Process in Adrenocortical Carcinoma
Fazio, P. D., Rusche, F. D., Roth, S., Pehl, A., Wächter, S., Mintziras, I., Bartsch, D. K., & Holzer, K. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.2001483 · Cited by 7
Kalomeris, T. A., Assaad, M. A., la Mora, J. D.-D., Gundem, G., Levine, M. F., Boyraz, B., Manohar, J., Sigouros, M., Medina-Martinez, J. S., Sboner, A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155725 · Cited by 7
Uruç, F., Ürkmez, A., Yüksel, Ö. H., Şahin, A., & Verit, A. (2015) · Canadian Urological Association Journal · doi:10.5489/cuaj.2867 · Cited by 7
Metastatic adrenal cortical carcinoma to T12 vertebrae
Lee, D. K., Yanamadala, V., Shankar, G. M., & Shin, J. H. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.11.009 · Cited by 7
James, F. V., Nair, L. M., Krishna, K. M. J., Kumar, A. A., Mathews, S., & Joseph, J. (2019) · Indian Journal of Urology · doi:10.4103/iju.iju_19_19 · Cited by 7
Risk factors associated with positive resection margins in patients with adrenocortical carcinoma
Skertich, N. J., Tierney, J. F., Chivukula, S. V., Babazadeh, N. T., Hertl, M., Poirier, J., & Keutgen, X. M. (2020) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2020.02.043 · Cited by 7
Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET
Raygada, M. J., Raffeld, M. A., Bernstein, A., Miettinen, M., Glod, J. W., Hughes, M. S., Reilly, K. M., Widemann, B. C., & Rivero, J. D. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62099 · Cited by 7
Case Report: Ectopic Adrenocortical Carcinoma in the Ovary
Tsai, W.-H., Chen, T.-C., Dai, S.-H., & Zeng, Y.-H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.662377 · Cited by 7
Williams, J. L., Smith, C., Hall, C. L., Khaled, Z., Maharaj, A. V., Kwong, R. M. W., Pittaway, J. F. H., Casas, J., Parvanta, L., Abdel‐Aziz, T., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvac007 · Cited by 7
Elfiky, A. A. (2015) · Surgical pathology clinics · doi:10.1016/j.path.2015.07.002 · Cited by 7
Identification of Seven Aberrantly Methylated and Expressed Genes in Adrenocortical Carcinoma
Xiao, H., He, W., Chen, P., Xu, D., Zeng, G., Li, Z. Y., Huang, M., Wang, X., DiSanto, M. E., & Zhang, X. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00472 · Cited by 7
The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study
Creemers, S. G., Feelders, R. A., Valdés, N., Ronchi, C. L., Volante, M., van Hemel, B. M., Luconi, M., Ettaieb, M. H. T., Mannelli, M., Chiara, M., et al. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0378 · Cited by 7
Kaštelan, D., Muzurović, E. M., & Dušek, T. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000626 · Cited by 7
Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
Liang, W., & Sun, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.538364 · Cited by 7
A novel cuproptosis‐related prognostic gene signature in adrenocortical carcinoma
Gao, W., He, X.-Y., Huangfu, Q., Xie, Y., Chen, K., Sun, C., Wei, J., & Wang, B. (2023) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24981 · Cited by 6
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma
Michalski, K., Schlötelburg, W., Hartrampf, P. E., Kosmala, A., Buck, A. K., Hahner, S., & Schirbel, A. (2023) · Pharmaceuticals · doi:10.3390/ph17010025 · Cited by 6
Clinical and Pathological Predictors of Death for Adrenocortical Carcinoma
Pato, E. Z. S., Srougi, V., Zerbini, C., Ledesma, F. L., Tanno, F. Y., Almeida, M. Q., Nahas, W. C., Latronico, A. C., Mendonca, B. B., Chambo, J. L., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad170 · Cited by 6
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Schlötelburg, W., Hartrampf, P. E., Kosmala, A., Fuß, C. T., Serfling, S. E., Buck, A. K., Schirbel, A., Kircher, S., Hahner, S., Werner, R. A., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03695-6 · Cited by 8
Atallah, S., Alassaf, H., Xu, Y., & El-Sayed, S. M. (2017) · Current Oncology · doi:10.3747/co.24.3533 · Cited by 6
Garay-Lechuga, D., Pérez-Soto, R. H., Hernández-Acevedo, J. D., Butrón-Hernández, D., Sierra‐Salazar, M., Pantoja‐Millán, J. P., Herrera, M. F., & Velázquez‐Fernández, D. (2021) · Surgery · doi:10.1016/j.surg.2021.04.042 · Cited by 6
MacKinney, E. C., Holoubek, S. A., Khokar, A. M., Kuchta, K. M., Moo‐Young, T. A., Prinz, R. A., & Winchester, D. J. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.01.004 · Cited by 6
Pregnancy in patients with adrenocortical carcinoma: a case-based discussion
Puglisi, S., Basile, V., Sperone, P., & Terzolo, M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09769-y · Cited by 7
Surgical management of metastatic adrenocortical carcinoma
Passman, J. E., Amjad, W., Ginzberg, S. P., Ballester, J. M. S., Finn, C. B., & Wachtel, H. (2023) · World Journal of Surgery · doi:10.1002/wjs.12014 · Cited by 7
Integration of molecular imaging in the personalized approach of patients with adrenal masses
Lorusso, M., RUFINI, V., CREA, C. D., Pennestrì, F., BELLANTONE, R., & RAFFAELLI, M. (2022) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.22.03449-5 · Cited by 6
Prevalencia e incidencia de los principales trastornos endocrinos y metabólicos
Liberman, G. C. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70217-7 · Cited by 6
Resektionsstrategie bei Nebennierenrindenkarzinomen
Schimmack, S. J., & Strobel, O. (2018) · Der Chirurg · doi:10.1007/s00104-018-0712-4 · Cited by 6
Surgery of adrenocortical cancer
Harrison, B. J. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.003 · Cited by 6
Jannello, L. M. I., Siech, C., Baudo, A., de ANGELIS, M., Bello, F. D., Goyal, J. A., Tian, Z., Luzzago, S., Mistretta, F. A., LORENZIS, E. D., et al. (2024) · Minerva Endocrinology · doi:10.23736/s2724-6507.24.04185-x · Cited by 5
Avascular Necrosis of Femur as a Complication of Cushing’s Syndrome Due to Adrenocortical Carcinoma
Anand, A., Jha, C. K., Singh, P. K., Sinha, U., Ganesh, A., & Bhadani, P. P. (2022) · The American Surgeon · doi:10.1177/00031348221129510 · Cited by 5
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes
Brönimann, S., Garstka, N., & Mesut Remzi, A. (2022) · Current Opinion in Urology · doi:10.1097/mou.0000000000001045 · Cited by 5
Szkodziak, P. R. (2024) · American Journal of Cancer Research · doi:10.62347/qkwf9884 · Cited by 5
Minkiewicz, I. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.353 · Cited by 5
Japanese single-institution analysis of mitotane for patients with adrenocortical carcinoma
Ohmoto, A., Shigematsu, Y., Fukuda, N., Wang, X., Urasaki, T., Hayashi, N., Sato, Y., Nakano, K., Yunokawa, M., Ono, M., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0277 · Cited by 5
Factors Associated with Non–Operative Management of Resectable Adrenocortical Carcinoma
Tseng, J., DiPeri, T. P., Chen, Y., Ben-Shlomo, A., Shouhed, D., Phillips, E. H., Burch, M. A., & Jain, M. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.06.013 · Cited by 5
Zhou, H., Zou, M., Ding, X., & Zou, F. (2021) · Cancer Management and Research · doi:10.2147/cmar.s316599 · Cited by 5
Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma
Passman, J. E., Amjad, W., Ballester, J. M. S., Ginzberg, S. P., & Wachtel, H. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14533-w · Cited by 6
Adrenal Causes of Cushing’s Syndrome
Cavagnini, F., & Giraldi, F. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00103-7 · Cited by 5
Wang, W., Chang, G., Sun, Y., Zhuo, R., Li, H., Hu, Y., & Ye, C. (2021) · Journal of Investigative Surgery · doi:10.1080/08941939.2021.1968981 · Cited by 5
Allolio, B., & Faßnacht, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00106-4 · Cited by 5
Bonnet-Serrano, F., Thomeret, L., Benanteur, N., Vaduva, P., Violon, F., Bouys, L., Ragazzon, B., Berthon, A. S., Perlemoine, K., Wilmot-Roussel, H., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf129 · Cited by 4
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy
Canu, L., Sparano, C., Naletto, L., Filpo, G. D., Cantini, G., Rapizzi, E., Martinelli, S., Ercolino, T., Cioppi, F., Fantoni, A., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1320722 · Cited by 4
Ma, S., Wu, L., Ye, L., Habra, M. A., Balderrama-Brondani, V., & Wang, W. (2025) · Endocrine · doi:10.1007/s12020-025-04163-5 · Cited by 4
Adrenal Cortex Tumors and Hyperplasias
Pignatelli, D. (2011) · InTech eBooks · doi:10.5772/19108 · Cited by 4
Adrenal cortical carcinoma with tumor thrombus extension into the right atrium: A case report
Wang, Y., Zhou, F., Pan, H., & Jin, B. (2016) · Oncology Letters · doi:10.3892/ol.2016.4502 · Cited by 5
Punjani, N., Clark, R. K., Izawa, J. I., Chin, J. L., Pautler, S. E., & Power, N. E. (2017) · Canadian Urological Association Journal · doi:10.5489/cuaj.4650 · Cited by 4
Mitochondria and Brain Disorders
Baloyannis, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77668 · Cited by 4
Yamamoto, A., Nakai, Y., Oka, T., Kanaki, T., Yamamoto, Y., Nagahara, A., Nakayama, M., Kakimoto, K., & Nishimura, K. (2020) · IJU Case Reports · doi:10.1002/iju5.12214 · Cited by 4
Adrenocortical Cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes
Zografos, G., Kassi, E. N., Parianos, C., Kyriakopoulos, G., Kostakis, I. D., Ansari, N. N., Aggeli, C., Dimitriadi, A., Angelousi, A. G., Papavassiliou, A. G., et al. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1666-9026 · Cited by 4
Hasebe, M., Shibue, K., Honjo, S., & Hamasaki, A. (2021) · QJM · doi:10.1093/qjmed/hcab276 · Cited by 4
Khosla, D., Kapoor, R., Singla, A. K., Periasamy, K., Goyal, S., Madan, R., Kumar, N., Behera, A., Singh, S. K., Bhadada, S. K., et al. (2023) · Rare Tumors · doi:10.1177/20363613231160699 · Cited by 5
Varma, M., Bhandari, R., & Kuhad, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01247-x · Cited by 4
Surgical resection for adrenocortical carcinoma: Current trends affecting survival
Shah, M., NeMoyer, R. E., Kashyap, R., Lin, Y., Sarmiento, J. M., Kooby, D. A., Maithel, S. K., Gillespie, T. W., Laird, A. M., & Shah, M. M. (2022) · Journal of Surgical Oncology · doi:10.1002/jso.26845 · Cited by 5
Adrenocortical carcinoma: Retrospective analysis of the last 22 years
Guelho, D., Paiva, I., Vieira, A., & Carrilho, F. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.12.009 · Cited by 4
Werner Syndrome and Diabetes Mellitus Accompanied by Adrenal Cortex Cancer
Nishioka, M., Kamei, S., Kinoshita, T., Sanada, J., Fushimi, Y., Irie, S., Hirata, Y., Tanabe, A., Hirukawa, H., Kimura, T., et al. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.8231 · Cited by 4
Jannello, L. M. I., Baudo, A., Scheipner, L., de ANGELIS, M., Siech, C., Bello, F. D., Goyal, J. A., Vitucci, K., Tian, Z., Luzzago, S., et al. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-04180-9 · Cited by 3
Rao, S. N., & Habra, M. A. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0247-9 · Cited by 3
Adrenocortical carcinoma’s incidence and mortality in central Serbia
Jovanovic, M. D., Zivaljevic, V. R., Diklić, A., Slijepčević, N., Tausanovic, K. M., Stevanovic, K. S., & Paunovic, I. R. (2017) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh160201006j · Cited by 3
Adrenocortical Carcinoma - A 25 Years Tertiary Centre Experience and Short Review of the Literature
Nunes, J. M. (2018) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2018.06.00148 · Cited by 3
Emerging drugs for the treatment of adrenocortical carcinoma
Sukrithan, V., Husain, M., Kirschner, L. S., Shah, M. H., & Konda, B. (2021) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2021.1920922 · Cited by 3
Trends in the incidence of adrenocortical carcinoma and pheochromocytoma/paraganglioma in Taiwan
Tsai, C., Huang, T., & Cheng, S. (2023) · Formosan Journal of Surgery · doi:10.1097/fs9.0000000000000072 · Cited by 3
Older age impacts outcomes after adrenalectomy
Green, R. L., Gao, T. P., Hamilton, A. E., & Kuo, L. E. Y. (2023) · Surgery · doi:10.1016/j.surg.2023.06.007 · Cited by 3
Validated predictive model for treatment and prognosis of adrenocortical carcinoma
Zuber, S. M., Kuchta, K. M., Holoubek, S. A., Khokar, A. M., Moo‐Young, T. A., Prinz, R. A., & Winchester, D. J. (2023) · Surgery · doi:10.1016/j.surg.2023.08.047 · Cited by 3
Pathology Associated with Hormones of Adrenal Cortex
Nigam, L. K., Vanikar, A. V., Patel, R., Kanodia, K. V., & Suthar, K. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.84815 · Cited by 3
Exploring the role of systemic therapy in adult adrenocortical carcinoma: A single-center experience
Prabhash, K., Kapoor, A., Noronha, V., Toshniwal, A., Menon, S. G., Joshi, A. D., Patil, V. M., Menon, N. N., Prakash, G. J., Murthy, V., et al. (2020) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_113_20 · Cited by 3
Metadata
- Authors
- Kebebew, E., Reiff, E., Duh, Q., Clark, O. H., & McMillan, A.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Kebebew, Electron
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2006-03-10
- Volume
- 30
- Issue
- 5
- Pages
- 872-878
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W2096051245
- Cited by
- 451
- References
- 21
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 28 · 2023: 35 · 2022: 33 · 2021: 47 · 2020: 44 · 2019: 30 · 2018: 27 · 2017: 25 · 2016: 21 · 2015: 35 · 2014: 12 · 2013: 14 · 2012: 17
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- World Journal of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenal incidentaloma, adrenalectomy, tumor size, tumor grade, TNM stage, distant metastasis, surgical resection, external beam radiotherapy, cause-specific mortality, survival predictors, temporal trends in diagnosis
- MeSH terms
- Adolescent, Adrenal Cortex Neoplasms, Adrenalectomy, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Neoplasm Staging, Retrospective Studies, United States, Cohort Studies, Treatment Outcome, Adrenocortical Carcinoma, SEER Program, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review